Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccination in Cardiac Surgery Patients
NCT02565277Phase 4Completed
- Sponsor
- Health Sciences North Research Institute
- Start
- Sep 2015
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Health Sciences North Research Institute. Started Sep 2015; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02565277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565277.